Trial NCT00570674

View at ClinicalTrials.gov 
Org. Study IDs: 07-069

Last trial update was posted on 2017-11-13

MeSH Interventions

Albumin-Bound Paclitaxel Carboplatin Cetuximab Paclitaxel

MeSH Conditions

Carcinoma Carcinoma, Adenosquamous Carcinoma, Squamous Cell Head and Neck Neoplasms Squamous Cell Carcinoma of Head and Neck

Other Conditions

Adenosquamous Cell Carcinoma Basaloid Squamous Cell Carcinoma Squamous Cell Carcinoma of the Head and Neck Undifferentiated Carcinoma

Stopping Reasons

The study did not continue to phase II due to the importance of HPV status as a prognostic factor to guide treatment decisions.

Limitations And Caveats

The phase II portion planned to enroll 34 participants including the expansion cohort but the study did not continue beyond phase I given the importance of HPV status as a prognostic factor to guide treatment decisions.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID